Exact Mass: 353.2849110000001

Exact Mass Matches: 353.2849110000001

Found 35 metabolites which its exact mass value is equals to given mass value 353.2849110000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Palmitoyl Proline

1-hexadecanoylpyrrolidine-2-carboxylic acid

C21H39NO3 (353.29297840000004)


N-palmitoyl proline belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Proline. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Proline is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Proline is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Oleoyl Alanine

2-[(1-Hydroxyoctadec-9-en-1-ylidene)amino]propanoate

C21H39NO3 (353.29297840000004)


N-oleoyl alanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Oleic acid amide of Alanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Oleoyl Alanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Oleoyl Alanine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Tetradecadienyl-l-carnitine

3-Hydroxy-3-[(trimethylazaniumyl)methyl]heptadeca-4,6-dienoic acid

C21H39NO3 (353.29297840000004)


   
   

Oleoyl sarcosine

2-(N-Methyloleamido)acetic acid

C21H39NO3 (353.29297840000004)


   

Oleyl sarcosine

2-(N-Methyloleamido)acetic acid

C21H39NO3 (353.29297840000004)


CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6217; ORIGINAL_PRECURSOR_SCAN_NO 6216 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6218; ORIGINAL_PRECURSOR_SCAN_NO 6216 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6223; ORIGINAL_PRECURSOR_SCAN_NO 6221 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6232; ORIGINAL_PRECURSOR_SCAN_NO 6231 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6315; ORIGINAL_PRECURSOR_SCAN_NO 6314 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6201; ORIGINAL_PRECURSOR_SCAN_NO 6198 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 11393; ORIGINAL_PRECURSOR_SCAN_NO 11388 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 11413; ORIGINAL_PRECURSOR_SCAN_NO 11410 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 11450; ORIGINAL_PRECURSOR_SCAN_NO 11448 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 11464; ORIGINAL_PRECURSOR_SCAN_NO 11462 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 11435; ORIGINAL_PRECURSOR_SCAN_NO 11433 CONFIDENCE standard compound; INTERNAL_ID 336; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 11483; ORIGINAL_PRECURSOR_SCAN_NO 11482

   
   

(8R)-9-((1S,Z)-1-hydroxy-1-methylhexahydro-2H-quinolizin-3(4H)-ylidene)-5,8-dimethylnonane-3,4-diol

(8R)-9-((1S,Z)-1-hydroxy-1-methylhexahydro-2H-quinolizin-3(4H)-ylidene)-5,8-dimethylnonane-3,4-diol

C21H39NO3 (353.29297840000004)


   
   

N-oleoyl alanine

N-(9Z-octadecenoyl)-alanine

C21H39NO3 (353.29297840000004)


   

NA 21:2;O2

N-(9Z-octadecenoyl)-alanine

C21H39NO3 (353.29297840000004)


   
   

Benzenemethanaminium,ar-dodecyl-N,N,N-trimethyl-, chloride (1:1)

Benzenemethanaminium,ar-dodecyl-N,N,N-trimethyl-, chloride (1:1)

C22H40ClN (353.2849110000001)


   
   

benzyldimethyl(tridecyl)ammonium chloride

benzyldimethyl(tridecyl)ammonium chloride

C22H40ClN (353.2849110000001)


   
   

Tetradecadienyl-l-carnitine

3-Hydroxy-3-[(trimethylazaniumyl)methyl]heptadeca-4,6-dienoic acid

C21H39NO3 (353.29297840000004)


   

2-[[(E)-octadec-9-enoyl]amino]propanoic acid

2-[[(E)-octadec-9-enoyl]amino]propanoic acid

C21H39NO3 (353.29297840000004)


   

(4E,6E)-3-hydroxy-3-[(trimethylazaniumyl)methyl]heptadeca-4,6-dienoate

(4E,6E)-3-hydroxy-3-[(trimethylazaniumyl)methyl]heptadeca-4,6-dienoate

C21H39NO3 (353.29297840000004)


   

N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]acetamide

C21H39NO3 (353.29297840000004)


   

N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]propanamide

C21H39NO3 (353.29297840000004)


   

N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]butanamide

C21H39NO3 (353.29297840000004)


   

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]heptanamide

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]heptanamide

C21H39NO3 (353.29297840000004)


   

N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]pentanamide

N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]pentanamide

C21H39NO3 (353.29297840000004)


   

N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]hexanamide

N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]hexanamide

C21H39NO3 (353.29297840000004)


   

(Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tridec-9-enamide

(Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tridec-9-enamide

C21H39NO3 (353.29297840000004)


   

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]nonanamide

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]nonanamide

C21H39NO3 (353.29297840000004)


   

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octanamide

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]octanamide

C21H39NO3 (353.29297840000004)


   

3-(1,2,2,6,6-Pentamethyl-1,2,3,6-tetrahydro-4-pyridinyl)-2-(2-methyl-2-aminopropyl)-1-methylindole

3-(1,2,2,6,6-Pentamethyl-1,2,3,6-tetrahydro-4-pyridinyl)-2-(2-methyl-2-aminopropyl)-1-methylindole

C23H35N3 (353.28308300000003)